Live

CellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy Endpoints NewsBiopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and more Science Daily BiotechThe secret language behind animal cooperation Endpoints NewsEndpoints News History: 10 Years, Bootstrap to FT Clinical OMICsImproving HSV-2 Vaccine Efficacy with Combination Strategy CellMultimodal imaging of gene expression, morphology, and activity of the same neuron 10x Genomics News10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics - Zacks Investment Research FierceBiotechFDA warning slams Zoll Medical with multiple quality control and reporting violations BioWorldHangzhou Innogate Pharma discovers new KAT inhibitors BioWorldAlicorn synthesizes new AAK1 inhibitors BioWorldChinese scientists identify new macrocyclic compounds as kinase inhibitors BioWorldNew VAV1 degradation inducers reported in Haisco Pharmaceutical Group patents

Archive

Latest Oldest Clear

Total 62

Page 4 / 4

Query --

BioPharma Dive Dec 19, 2025

Patient deaths put Merck, Daiichi’s ADC trial on partial hold

FierceBiotech Dec 19, 2025

Merck turns down option to Evaxion's gonorrhea vaccine, prompting Danish biotech to seek other partners

Endpoints News Dec 18, 2025

Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths

BioWorld Dec 9, 2025

Merck Sharp & Dohme discovers new GTPase KRAS degradation inducers

FierceBiotech Dec 9, 2025

ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap

Endpoints News Dec 8, 2025

Merck outbid three competitors in Cidara acquisition — new filing

Endpoints News Dec 5, 2025

German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme

BioPharma Dive Nov 25, 2025

Kelun, Merck tout ADC as potential first-line treatment in lung cancer